Estrogen-related receptor alpha (ERR) is a nuclear receptor that controls genes involved in energy metabolism, mitochondrial function, and oxidative capacity
During this meeting, the advisory committee will: Review available safety and efficacy data for BPC-157, including preclinical studies and any available clinical evidence Consider public comments submitted by patients, practitioners, and industry stakeholders Evaluate the clinical need for compounded BPC-157 and the patient populations that would benefit Assess the compounding quality considerations specific to peptide formulations Issue a recommendation to the FDA on whether BPC-157 should be included on the 503A compounding list Possible outcomes include: Positive recommendation: PCAC advises the FDA to add BPC-157 to the 503A list, clearing the way for legal compounding nationwide
ClinicalTrials.gov no completed 5-Amino-1MQ human efficacy trial (evidence-gap note)
Superiority of a vitamin B(12)-containing emollient compared to a standard emollient in the maintenance treatment of mild-to-moderate plaque psoriasis
No, CJC-1295 does not increase testosterone
Knowing your before and after results helps create honest hopes and builds belief in the method
